See the DrugPatentWatch profile for vascepa

The maximum number of Vascepa refills allowed by your insurance depends on various factors, including the specific terms of your insurance policy. These factors can include the prescription policy set by your insurance provider, the dosage prescribed by your healthcare provider, and the duration of the prescription.

To find specific information about your insurance coverage for Vascepa, it's recommended to contact your insurance provider directly. They can provide you with the most accurate and up-to-date information regarding your prescription drug coverage.

However, it's worth noting that Vascepa (generic name: icosapent ethyl) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with severe hypertriglyceridemia (triglyceride levels ≥500 mg/dL). As of March 2023, Vascepa is still under patent protection, which may impact its availability and cost. According to DrugPatentWatch.com, the earliest generic version of Vascepa is expected to become available in June 2026 [1].

In summary, the maximum number of Vascepa refills allowed by your insurance depends on your specific insurance policy and coverage. It's best to contact your insurance provider for accurate information. Additionally, Vascepa is still under patent protection, which may affect its availability and cost.

Sources:
[1] DrugPatentWatch.com. (2023). Vascepa (icosapent ethyl) Drug Patent Information. Retrieved from <https://www.drugpatentwatch.com/drugs/vascepa.html>